Search research articles
Contact Us
Filters
Showing results (81-90 of 110) with videos related to
Page
of 11
Sort By:
International Journal of Cancer
|
July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg
Sebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.
International Journal of Cancer
|
May 16, 2026
Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany
Glenn Geidel, Theresa Lowinus, Patrick Metzger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
Oncotarget
|
May 6, 2017
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression
Hana Andrlová, Justin Mastroianni, Josef Madl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 28, 2023
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Anne Zaremba, Peter Mohr, Ralf Gutzmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 21, 2022
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG
Sophia Kreft, Valerie Glutsch, Anne Zaremba, et al.
Nature Immunology
|
December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cells
Zhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 110) with videos related to
Sort By:
Page
of 11
International Journal of Cancer
|
July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg
Sebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.
International Journal of Cancer
|
May 16, 2026
Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany
Glenn Geidel, Theresa Lowinus, Patrick Metzger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
Oncotarget
|
May 6, 2017
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression
Hana Andrlová, Justin Mastroianni, Josef Madl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 28, 2023
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Anne Zaremba, Peter Mohr, Ralf Gutzmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 21, 2022
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG
Sophia Kreft, Valerie Glutsch, Anne Zaremba, et al.
Nature Immunology
|
December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cells
Zhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Page
of 11